Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Citigroup
C
|
+$702M |
| 2 |
Applied Materials
AMAT
|
+$507M |
| 3 |
Keurig Dr Pepper
KDP
|
+$387M |
| 4 |
KeyCorp
KEY
|
+$383M |
| 5 |
Visa
V
|
+$349M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$948M |
| 2 |
Broadcom
AVGO
|
+$446M |
| 3 |
NXP Semiconductors
NXPI
|
+$434M |
| 4 |
Analog Devices
ADI
|
+$309M |
| 5 |
Lam Research
LRCX
|
+$269M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 6.16% |
| 2 | Technology | 4.5% |
| 3 | Industrials | 4.26% |
| 4 | Consumer Discretionary | 4.07% |
| 5 | Healthcare | 3.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PIR
8051
CALL
DELISTED
Pier 1 Imports, Inc.
PIR
| $106K | ﹤0.01% |
2,225
-360
| -14% | -$19.5K |
|
|
ADVM
8052
CALL
DELISTED
Adverum Biotechnologies
ADVM
| $105K | ﹤0.01% |
+1,980
| New | +$119K |
|
8053
Anavex Life Sciences
AVXL
$250M
| $105K | ﹤0.01% |
40,171
+17,544
| +78% | +$49K |
|
|
PDS
8054
PUT
Precision Drilling
PDS
$979M
| $105K | ﹤0.01% |
1,580
-5
| -0.3% | -$336 |
|
8055
CALL
Alto Ingredients
ALTO
$358M
| $104K | ﹤0.01% |
40,100
-700
| -2% | -$2.23K |
|
8056
PUT
Rigel Pharmaceuticals
RIGL
$704M
| $104K | ﹤0.01% |
3,670
-1,200
| -25% | -$42.7K |
|
8057
Radiant Logistics
RLGT
$388M
| $104K | ﹤0.01% |
+26,635
| New | +$104K |
|
8058
CALL
Talphera
TLPH
$70.3M
| $104K | ﹤0.01% |
1,540
+20
| +1% | +$1.19K |
|
|
FENG
8059
PUT
Phoenix New Media
FENG
$17.5M
| $103K | ﹤0.01% |
+4,050
| New | +$112K |
|
8060
PUT
Jakks Pacific
JAKK
$302M
| $103K | ﹤0.01% |
3,140
+640
| +26% | +$17K |
|
|
DMK
8061
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
| $103K | ﹤0.01% |
458
-712
| -61% | -$191K |
|
|
TIS
8062
PUT
DELISTED
Orchids Paper Products, Inc.
TIS
| $103K | ﹤0.01% |
+26,000
| New | +$148K |
|
|
NIHD
8063
DELISTED
NII Holdings, Inc. Common Stock
NIHD
| $103K | ﹤0.01% |
26,472
-20,764
| -44% | -$56.7K |
|
8064
CALL
Babcock & Wilcox
BW
$1.41B
| $102K | ﹤0.01% |
4,300
-3,590
| -46% | -$95.4K |
|
8065
PUT
MannKind Corp
MNKD
$1.27B
| $102K | ﹤0.01% |
53,500
+2,500
| +5% | +$4.68K |
|
|
PTX
8066
CALL
DELISTED
Pernix Therapeutics Holdings, Inc.
PTX
| $102K | ﹤0.01% |
42,000
+26,300
| +168% | +$64.4K |
|
8067
PUT
Ardelyx
ARDX
$1.25B
| $101K | ﹤0.01% |
27,200
+16,200
| +147% | +$75.2K |
|
8068
DHI Group
DHX
$176M
| $101K | ﹤0.01% |
+43,163
| New | +$87.4K |
|
8069
CALL
ReposiTrak
TRAK
$157M
| $101K | ﹤0.01% |
+12,800
| New | +$106K |
|
|
SHLO
8070
DELISTED
Shiloh Industries Inc
SHLO
| $101K | ﹤0.01% |
11,624
+1,587
| +16% | +$14.6K |
|
|
AVEO
8071
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
| $101K | ﹤0.01% |
+4,490
| New | +$106K |
|
|
FLNT
8072
Fluent
FLNT
$104M
| $100K | ﹤0.01% |
6,790
-8,425
| -55% | -$137K |
|
8073
PUT
Navios Maritime Partners
NMM
$2.25B
| $100K | ﹤0.01% |
3,527
-1,980
| -36% | -$54K |
|
8074
CALL
VEON
VEON
$3.66B
| $100K | ﹤0.01% |
1,676
-284
| -14% | -$17.8K |
|
8075
CALL
Verastem
VSTM
$536M
| $100K | ﹤0.01% |
+1,208
| New | +$74K |
|
Similar funds
Citadel Advisors's Q2 2018 Portfolio in Review
As of Q2 2018, Citadel Advisors held 9,765 positions worth $203B, up 11% from $184B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Citadel Advisors deployed $8.95B of net new capital in Q2 2018, opening 1,572 new positions and adding to 4,160 existing holdings. Its largest new stake was Equitable Holdings: 16,008,962 shares worth $330M.
By sector, the portfolio is most concentrated in Financials at 6.2% of assets, up from 4.9% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $948M trimmed.
- Citadel Advisors's largest Q2 2018 buy was Equitable Holdings: 16,008,962 shares worth $330M.
- Citadel Advisors added most to Citigroup in Q2 2018, an estimated $702M increase.
- Citadel Advisors's biggest Q2 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $948M.
- Citadel Advisors fully exited Time Warner Inc in Q2 2018, selling an estimated $268M.
- Citadel Advisors's ten largest holdings make up 24% of its $203B portfolio in Q2 2018.
- Citadel Advisors opened 1,572 new positions and closed 1,012 in Q2 2018.
- Citadel Advisors's portfolio value rose 11% quarter-over-quarter to $203B.
Based on Citadel Advisors's 13F filing for Q2 2018, filed 10 Aug 2018.